Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Evome Medical Technologies Inc LNDZF


Primary Symbol: V.EVMT

Evome Medical Technologies Inc. is an international medical device company, which is focused on human performance and rehabilitative solutions. The Company’s products include Biodex Rehab product, Damar Plastics product, Mio-Guard product, Simbex services, and SDP product. Its Biodex Rehab products include Isokinetic Systems, Gait Trainer, Body-Weight Supported Training, Cycles and Ergometers, and Squat-Assist Trainer. Its Mio-Guard products include bags, cases and kits, braces, and supports, diagnostics and instruments, furniture, and equipment, padding and splinting, personal protection, sanitizers and disinfectants, and tapes and wraps. Its applications include fall risk screening and conditioning, patient-driven payment model (PDPM), wellness, sports medicine solutions, neurological involvement, safe patient handling and mobility, and senior living and rehabilitation. It offers concussion, fall screening and balance assessment and training programs.


TSXV:EVMT - Post by User

Comment by subaru1on May 30, 2024 10:43am
95 Views
Post# 36064365

RE:Is it just me

RE:Is it just me You are not alone, i went on Sedar to find out more detail, zap nothing more other then nice word again by the CEO, are we screw again.
CEO words.
Going forward,the Company expects to have a strongsecond quarter generating positive Adjusted EBITDA (defined below). “With many of the divestment and cost cutting parts of the turn-around plan behind us, we are now foc used on the growth phase of the turnaround plan,” said CEO Mike Seckler. “By the e nd of the second quarter, Evome will truly be a new company. In less than a yea r, we were able to decrease costs, increase Biodex revenue and divest non-core assets to reduce our debt. With our debt issues largely contained, we c an focus on adding c ash to the balance sheet from generating profits, as well as launching our new products in new and c urrent markets. I look forward to introducing the new Evome to the markets with our update c all ne xt we e k and the n with fac e -to-fac e me e tings ove r the summer.
He had words like that regarding the 1qrt..
Unbeleivable.
<< Previous
Bullboard Posts
Next >>